Search Results 581-590 of 19230 for hemoglobin

1. A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) - Mayo Clinic

   ... hemoglobin <8 g/dL. 4. No suitable fully matched related donor available (minimum 6/6 match for HLA-A and B at intermediate or high resolution and DRB1 at ...

2. Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors - Mayo Clinic

   - Hemoglobin ≥ 9 g/dL (a transfusion is allowed if Hemoglobin stays stable thereafter); - Absolute neutrophil count (ANC) ≥ 1,000 cells/mm^3; - Platelet ...

3. A Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors - Mayo Clinic

   Hemoglobin ≥ 8.5 g/dL. Adequate other organ functions as defined by the following: Alanine aminotransferase (ALT) and (aspartate aminotransferase) AST ≤ 3x ...

4. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   Hemoglobin ≥.0 g/dL;; Serum total bilirubin ≤.5× ULN or ≤× ULN for subjects with Gilbert's disease;; Serum ALT and AST ≤× ULN (≤× ULN if evidence of ...

5. Stories for Change: Digital Storytelling for Diabetes Self-Management Among Somali Adults - Mayo Clinic

   Most recent hemoglobin A1c ≥ 8%. Exclusion Criteria: Not eligible if someone in the same household is participating in the study. Participating Mayo Clinic ...

6. A Study to Assess Effectiveness and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly - Mayo Clinic

   Patients with poorly controlled diabetes mellitus (hemoglobin A1c > 8.0%). Participating Mayo Clinic locations. Study statuses change often. Please contact ...

7. A Study of Response, Survival, Safety, and Tolerability of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL (can be corrected by growth factor or transfusion); Platelet count ≥ 100 x 10^9/L. Adequate blood coagulation function as evidenced by ...

8. A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults with Idiopathic Pulmonary Fibrosis - Mayo Clinic

   Hemoglobin-corrected diffusion capacity for carbon monoxide (DLCO) ≥ 30% predicted normal 4) Be able to walk ≥ 100 meters unassisted. Key Exclusion ...

9. Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis - Mayo Clinic

   Hemoglobin >= 8 g/dl; Platelets >= 75,000/mm^3; Total bilirubin =< 1.5 x upper limits of normal (ULN); Serum glutamic oxaloacetic transaminase (SGOT) ...

10. Joint Replacement Surgery Clinical Trials - Mayo Clinic Research

    We will collect both non-invasive hemoglobin and conventional serum hemoglobin labs from patients postoperatively following outpatient total joint ...